![]() Of the University Hospital Erlangen mimic the effect of anĪctual infection, where the virus replicates in the host cellsĪnd then reinfects further cells, thereby spreading the Particles used in the cooperation with the virological institute Lentivirus data show the ability of Carragelose to prevent the Institute of the University Hospital Erlangen, Germany.Ĭarragelose showed similar effectiveness against the SARS-CoV-2 Variants (B1.1.7 and B1.351) were independently tested in VeroĬell tissue culture in cooperation with the virological HPMC and CMC were ineffective even at the highest concentrations Products: The marketed nasal sprays have a CarrageloseĬoncentration of 1.2 mg / ml, a more than 200-fold higher doseĪs shown to be effective in vitro. This isĬlinically relevant for the use of Carragelose-containing Carragelose was able to inactivateĪll four virus forms at concentrations below 5 µg/ml. Wild-type SARS-CoV-2 or one of the three variants B.1.1.7,ī1.351 and P1, respectively. Lentiviruses differently pseudotyped with the spike protein of In recent in vitro tests, Marinomed included four We believe that this will hold true for any future These new results we confirmed the hypothesis that ourĬarragelose-based products continue to be effective alsoĪgainst the mutations of concern currently emerging strongly. Unlikely to evade the antiviral efficacy of Carragelose. “ Given the broad antiviral efficacy and the physical mode ofĪction, we were convinced that SARS‑CoV‑2 variants are Eva Prieschl-Grassauer, Chief Scientific Officer at SARS-CoV-2, independent of the mutations we tested,” said Dr. We are veryĬonfident in these results that show Carragelose inactivates Taking over the dynamics of the pandemic. “ The COVID-19 pandemic continues to be a major health, social,Īnd economic burden, and we now see variants of SARS-CoV-2 The roll-out of vaccines, NONS can help get the world back Loss suffered by millions around the world. In numbers, and each day compounds the frustration, fear and “ The human toll of this disease cannot be expressed simply Gilly Regev, CEO and co-founder of SaNOtize. Get it into the hands of the public where it can help bringĪn end to the pandemic, accelerate a return to normality,Īnd prevent future outbreaks of COVID-19 and its variants,” said Dr. “ Now that NONS has been demonstrated to be safe andĮffective in clinical trials, we must move with urgency to State University’s Antiviral Research Institute. Phase 2 trials in Canada and independent lab tests at Utah Those who have yet to be vaccinated, NONS has alsoĭemonstrated that it could also reduce infectivity – theįrequency of transmission from an infected person to aĬorroborate the information gathered from SaNOtize’s earlier That could soon be widely available at low-cost for long-termĬare facilities, healthcare and frontline workers, and theĪntiviral treatment in the early stages of infection and for Manufacture, storage and use makes NONS a treatment candidate Spur an economic recovery that is months – if not years –Įquitable global availability of NONS could form a bridgeĭuring the global production and distribution of vaccines to SwiftĪpproval and ramp-up of manufacturing could facilitate anĪlmost immediate safe return to work, school and society, and The UK and Canada for Emergency Use authorization. SaNOtize is applying to regulatory authorities in SaNOtize Seeking Emergency Use Authorization in UK and Persistent pulmonary hypertension, or Blue Baby Syndrome, in Is identical to the one delivered in its gaseous form to treat Toxicity, and safety data for NO use in humans has been SARS-CoV-2, the virus that causes COVID-19. Natural nanomolecule produced by the human body with provenĪnti-microbial properties shown to have a direct effect on Virus in the upper airways, preventing it from incubating and The SaNOtize treatment is designed to kill the Supporting vaccines, preventing future outbreaks and safely The levels of SARS-CoV-2, which could be critical in Viral loads yet still demonstrated significant reductions in Our trial included patients with a variant of concern and high The treatment of COVID-19 and reducing onward transmission. “ This simple portable nasal spray could be highly effective in
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |